<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940318-2-00111</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The meeting, open to the public, will be on Monday,  <!-- PJG 0012 frnewline --> May 9, 1994 from 8 a.m. to 5 p.m. and Tuesday, May 10, 1994 from 8 a.m. to 5 p.m.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Agency for Health Care Policy and Research</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Public Meeting on Medical Treatment Effectiveness Research: Hysterectomy and Other Therapies Used in the Management of Common Noncancerous Uterine Conditions </DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Agency for Health Care Policy and Research, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Notice of public meeting.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  This notice announces a meeting on the subject of Medical Treatment Effectiveness Research: Hysterectomy and Other Therapies Used in the Management of Common Noncancerous Uterine Conditions.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The meeting, open to the public, will be on Monday,  <!-- PJG 0012 frnewline --> May 9, 1994 from 8 a.m. to 5 p.m. and Tuesday, May 10, 1994 from 8 a.m. to 5 p.m.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <ADDRESS> <!-- PJG ITAG l=10 g=1 f=2 --> ADDRESSES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The meeting will be at the Garden City Hotel, Garden City, Long Island, New York, 11530. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ADDRESS> <SUPPLEM> <!-- PJG ITAG l=84 g=1 f=2 --> SUPPLEMENTARY INFORMATION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 -->   <!-- PJG 0012 frnewline --> I. Purpose  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Section 1142 of the Social Security Act (42 U.S.C. 1320b-12) authorizes the Agency for Health Care Policy and Research (AHCPR) to conduct and support research on the outcomes, effectiveness, and appropriateness of health care services and procedures in order to identify the manner in which diseases, disorders, and other health conditions can most effectively and appropriately be prevented, diagnosed, treated, and managed clinically. The Medical Treatment Effectiveness Program (MEDTEP) is described in the Catalog of Federal Domestic Assistance, No. 93.180.  <!-- PJG 0012 frnewline --> The purpose of this meeting is to conduct a critical review and discussion of the current science related to treatment effectiveness for common noncancerous uterine conditions, and to recommend to AHCPR appropriate and feasible medical effectiveness research strategies for the future. Topics will address what scientific evidence is available and what is known and not known about the effectiveness and outcomes of treatments for specific clinical conditions. These common conditions include dysfunctional uterine bleeding and pain, uterine prolapse (with and without urinary dysfunction), endometriosis, and leiomyomata (fibroids). The examination of treatment alternatives will include but not be limited to hysterectomy (including all surgical techniques), hormone therapy, other pharmacotherapy, laser technology, myomectomy, and watchful waiting.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> II. Agenda  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The opening plenary session will begin at 8 a.m. on May 9, 1994, and provide an overview of the topic and expectations for the meeting. Presentations, which will focus on: (1) Clinical perspectives and issues, (2) economic issues associated with treatment alternatives, and (3) issues in measurement of clinical, psychological, functional, and other outcomes, will follow with open discussion periods. Working groups will meet concurrently in the afternoon.  <!-- PJG 0012 frnewline --> A second set of working groups will meet concurrently on Tuesday, May 10, 1994. These groups will make reports and recommendations at the conclusion of the meeting.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> III. Arrangements for the May 9&hyph;10, 1994 Meeting  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Individuals and representatives of organizations who would like to attend the meeting must register by April 15, 1994 with Kristine Krutules, Walcoff &amp; Associates, the contractor providing administrative support to AHCPR for the meeting, at the address  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> set out below. Registration information and a draft agenda may be obtained by writing to Walcoff &amp; Associates, Attention:  <!-- PJG 0012 frnewline --> Kristine Krutules, 635 Slaters Lane, suite 400, Alexandria, Virginia 22314. Requests for registration materials may also be submitted by facsimile transmission at 703&hyph;548&hyph;0426, Attention: Kristine Krutules. Facsimile cover sheets should include a name, address, telephone number, and facsimile number to which materials may be transmitted.  <!-- PJG 0012 frnewline --> If sign language interpretation or other reasonable accommodation for a disability is needed, please contact Walcoff &amp; Associates, Attention Kristine Krutules by April 15, 1994 at the address listed above.  <!-- PJG 0012 frnewline --> Individuals and representatives of organizations may provide relevant written comments and information on hysterectomy and common noncancerous uterine conditions to Walcoff &amp; Associates by April 22, 1994. Copies of this information will be made available to the participants at the meeting.  <!-- PJG 0012 frnewline --> Additional information on the meeting can be obtained by contacting Jane D. Scott, Sc.D., Health Scientist Administrator, Center for Medical Effectiveness Research, Agency for Health Care Policy and Research, at the following address: Jane D. Scott, Sc.D., Coordinator, ``MEDTEP Conference: Uterine Conditions'', 2101 East Jefferson Street, suite 605, Rockville, Maryland 20852, Phone: 301&hyph;594&hyph;1485, FAX: 301&hyph;594&hyph;3211. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: March 11, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> J. Jarrett Clinton,  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Administrator.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;6370 Filed 3&hyph;17&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;90&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            